Cephea Valve Technologies - About the company
Cephea Valve Technologies is an acqui-hired company based in Santa Clara (United States), founded in 2013 by Frederic H Moll. It operates as an A catheter delivered Mitral Valve. Cephea Valve Technologies has raised $14.7M in funding. The company has 108 active competitors, including 49 funded and 28 that have exited. Its top competitors include companies like Cardiac Dimensions, Peijia Medical Technologies and MicroPort CardioFlow Medtech Corporation.
Company Details
Cephea Valve Technologies is developing a Catheter delivered Mitral Valve based on non-stent based anchoring technology. It intends to place the valve into the heart via a catheter threaded into the femoral vein.
- Website
- cephea.com
- Email ID
- *****@cephea.com
Key Metrics
Founded Year
2013
Location
Santa Clara, United States
Stage
Acqui-Hired
Total Funding
$14.7M in 1 round
Latest Funding Round
Investors
Ranked
75th among 108 active competitors
Employee Count
2 as on Apr 30, 2026
Similar Companies
Sign up to download Cephea Valve Technologies' company profile
Cephea Valve Technologies's funding and investors
Cephea Valve Technologies has raised a total funding of $14.7M over 1 round. Cephea Valve Technologies has 2 institutional investors.
Here is the list of recent funding rounds of Cephea Valve Technologies:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jan 12, 2015 | 8112307 | Series B | 9801174 | 3430394 | 7004801 | 8425540 |
Access funding benchmarks and valuations. Sign up today!View details of Cephea Valve Technologies's funding rounds and investors
Cephea Valve Technologies' founders and board of directors
Founder? Claim ProfileThe founders of Cephea Valve Technologies is Frederic H Moll.
Here are the details of Cephea Valve Technologies' key team members:
- Frederic H Moll: Co-Founder & Chairman of Cephea Valve Technologies. They are also an angel investor in 1 startup.
View details of Cephea Valve Technologies's Founder profiles and Board Members
Cephea Valve Technologies' employee count trend
Cephea Valve Technologies has 2 employees as of Apr 26. Here is Cephea Valve Technologies's employee count trend over the years:
Uncover Cephea Valve Technologies' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Cephea Valve Technologies's Competitors and alternates
Top competitors of Cephea Valve Technologies include Cardiac Dimensions, Peijia Medical Technologies and MicroPort CardioFlow Medtech Corporation. Here is the list of Top 10 competitors of Cephea Valve Technologies, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Cardiac Dimensions 2001, Kirkland (United States), Series E | Developer of invasive cardiac implants for heart failure | $261M | 63/100 | |
2nd | Peijia Medical Technologies 2012, Suzhou (China), Public | Developer of medical devices for the treatment of cardiac and cerebrovascular diseases | $110M | 63/100 | |
3rd |  MicroPort CardioFlow Medtech Corporation 2015, Pudong (China), Public | Developer of smart medical devices for patients with heart valve diseases | $132M | 63/100 | |
4th | JenaValve Technology 2006, Irvine (United States), Acquired | Provider of pericardial transcatheter aortic valve replacement and delivery system | $364M | 62/100 | |
5th | Venus MedTech 2009, Hangzhou (China), Public | Transcatheter aortic valves | $37M | 61/100 | |
6th | Developer of a percutaneous device for treating tricuspid regurgitation | $43.9M | 58/100 | ||
7th | Developer of a minimally invasive tricuspid valve replacement system. This system is designed to treat tricuspid regurgitation, a serious heart condition, without the need for open-heart surgery. The company focuses on developing a safe and effective solution to address the limitations of existing treatment approaches. It is developing a catheter-based system for tricuspid valve replacement. The company's efforts include clinical trials and securing funding to support further development and clinical milestones. | $103M | 58/100 | ||
8th |  Foldax 2006, Salt Lake City (United States), Series D | Developer of bio-polymeric heart valves to treat aortic, mitral, and tricuspid valve diseases | $43.7M | 57/100 | |
9th |  Shockwave Medical 2009, Santa Clara (United States), Acquired | Developer of cardiovascular balloon dilation catheters | $148M | 56/100 | |
10th |  HighLife Medical 2010, Paris (France), Series B | Developer of trans-catheter mitral valve replacement system | $50.8M | 56/100 | |
75th | Cephea Valve Technologies 2013, Santa Clara (United States), Acqui-Hired | A catheter delivered Mitral Valve | $14.7M | 32/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Cephea Valve Technologies's competitors? Click here to see the top ones
Cephea Valve Technologies's Investments and acquisitions
Cephea Valve Technologies has made no investments or acquisitions yet.
News related to Cephea Valve Technologies
•
Abbott snaps up replacement mitral valve maker CepheaFierce Biotech•Jan 18, 2019•Abbott, Cephea Valve Technologies
•
Abbott To Acquire Cephea Valve Technologies, Inc.PR Newswire•Jan 16, 2019•Abbott, Cephea Valve Technologies
•
Abbott drops $250m on Tendyne, backs Cephea in mitral valve playMassDevice•Jul 30, 2015•Tendyne Holdings, Abbott, Cephea Valve Technologies
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Cephea Valve Technologies
Explore our recently published companies
